Literature DB >> 18042886

Pregabalin: its pharmacology and use in pain management.

Noor M Gajraj1.   

Abstract

Pregabalin is a new synthetic molecule and a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid. It is an alpha2-delta (alpha2-delta) ligand that has analgesic, anticonvulsant, anxiolytic, and sleep-modulating activities. Pregabalin binds potently to the alpha2-delta subunit of calcium channels, resulting in a reduction in the release of several neurotransmitters, including glutamate, noradrenaline, serotonin, dopamine, and substance P. In this review, I will discuss the pharmacology of pregabalin and available efficacy studies in pain management. This review will focus on the advances in pregabalin pharmacology since my previous review in 2005.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042886     DOI: 10.1213/01.ane.0000287643.13410.5e

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  87 in total

1.  Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons.

Authors:  Jared Minkel; Andrew D Krystal
Journal:  Sleep Med Clin       Date:  2013-09-01

2.  Effect of Oral Pregabalin as Preemptive Analgesic in Patients Undergoing Lower Limb Orthopedic Surgeries under Spinal Anaesthesia.

Authors:  Bon Sebastian; Anand Tippanna Talikoti; Kiran Nelamangala; Dinesh Krishnamurthy
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 3.  Pregabalin: a review of its use in fibromyalgia.

Authors:  Katherine A Lyseng-Williamson; M Asif A Siddiqui
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  [New substances and applications for postoperative pain therapy].

Authors:  E M Pogatzki-Zahn; P K Zahn
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 5.  Misuse and abuse of pregabalin and gabapentin: cause for concern?

Authors:  Fabrizio Schifano
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

Review 6.  New treatments for chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Adam C Strauss; Jordan D Dimitrakov
Journal:  Nat Rev Urol       Date:  2010-02-09       Impact factor: 14.432

7.  Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain.

Authors:  Lovish Marwaha; Yashika Bansal; Raghunath Singh; Priyanka Saroj; Rupinder Kaur Sodhi; Anurag Kuhad
Journal:  Inflammopharmacology       Date:  2016-10-18       Impact factor: 4.473

8.  Diagnosis and treatment of glossopharyngeal and vagal neuropathies in a patient with laryngopharyngeal reflux.

Authors:  Irina Lokshina; Igor Feinstein; Carole Agin; Robert Katz
Journal:  Anesthesiology       Date:  2008-10       Impact factor: 7.892

Review 9.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Oral pregabalin for postoperative pain relief after third molar extraction: a randomized controlled clinical trial.

Authors:  Maria Victoria Olmedo-Gaya; Francisco J Manzano-Moreno; Rafael Galvez-Mateos; Maria Paloma González-Rodriguez; Cristina Talero-Sevilla; Manuel Vallecillo-Capilla
Journal:  Clin Oral Investig       Date:  2015-11-18       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.